Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical trial NCT04003974 · COMPLETED
Trial details
- NCT number
- NCT04003974
- Sponsor
- Fulcrum Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-09
- Primary completion
- 2021-01-28
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.